Hypogammaglobulinemia, associated with compromised T- and nonclonal CD5- B cell functions, significantly impacts infection frequency and survival rates in patients with CLL (28, 29). The gene discussed is CD5; the disease is Decreased circulating immunoglobulin concentration.